Use access key #2 to skip to page content.
$3.46 -0.19 (-5.21%)
5/16/2008 3:41 PM

XTENT, Inc. (XTNT)

CAPS Rating:
*

A development stage medical device company, which focused on developing and commercializing its customizable drug eluting stent systems for the treatment of coronary artery disease or CAD.

View All Commentary (XTNT)

Recs

0

Avatar Mike4522 (< 20) Submitted: 12/11/07 4:57 PM : Outperform Start Price: $9.01 XTNT Score: -56.04

- DES market is on the rebound
- Breakthrough stent deployment technology
- Enhanced mesh stent design

Report this Post Replies: 0 | Reply

Featured Broker Partners